Latest Cost Control News

Scorpion Minerals has solidified its position in Western Australia’s Murchison region by acquiring the Old Prospect gold tenements and progressing strategic partnerships, setting the stage for extensive drilling and resource upgrades.

Sultan Resources pushes forward with exploration at key Lachlan Fold Belt porphyry targets while securing US OTC Market listing and maintaining a solid cash position.

Kingsgate Consolidated sustained robust production at Chatree with a fifth straight quarter exceeding 20,000 ounces of gold, while achieving a record AISC margin and boosting cash reserves to A$213 million.

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Appen Limited’s Q1 FY26 revenue rose 9% year-on-year to $54.8 million, driven by an 88% surge in its China business. Despite a 37% drop in the Global segment due to seasonality, the company reaffirmed full-year guidance and highlighted expanding AI operational efficiencies.

Top End Energy is progressing farm-out talks in the Beetaloo Basin amid growing industry validation, while its Kansas hydrogen project attracts new partners and it broadens into US AI data centre energy solutions.

Powerhouse Ventures holds $6.14 million in liquid assets and advances new technology fund launch despite challenging market conditions.

Dubber Corporation reported a historic positive underlying operating cashflow run-rate in Q3 FY26, driven by a USD 3.06 million initial payment from a Tier 1 North American communications service provider and ongoing cost reductions. Recurring revenue dipped 6% quarter-on-quarter due to portfolio optimisation and foreign exchange impacts.

Anatara Lifesciences delivered ambiguous mechanism of action results for its Anti-Obesity Project while reporting statistically significant weight management effects from compound AOC. The company plans a limited Phase 1 study but may delay it amid ongoing strategic discussions, with cash reserves tightening to $0.7 million.

West Wits Mining has poured its first gold at Qala Shallows, marking its transition to production, while securing substantial funding and advancing plans to scale output.

Liontown Limited has kicked off early works and long-lead procurement for its Kathleen Valley lithium expansion, ahead of a Final Investment Decision expected by March 2027.